Co-Authors
This is a "connection" page, showing publications co-authored by Gary Lyman and Nicole Kuderer.
Connection Strength
8.937
-
Opportunities and Challenges of Observational Studies and Randomized Controlled Trials for Evaluating the Therapeutic Efficacy of COVID-19 Convalescent Plasma. Cancer Invest. 2021 Jul-Aug; 39(6-7):449-456.
Score: 0.955
-
Challenges and Opportunities for COVID-19 Vaccines in Patients with Cancer. Cancer Invest. 2021 Mar; 39(3):205-213.
Score: 0.930
-
Challenges of Cancer Immunotherapy during the COVID-19 Pandemic. Cancer Invest. 2021 02; 39(2):115-119.
Score: 0.921
-
Randomized Controlled Trials Versus Real-World Data in the COVID-19 Era: A False Narrative. Cancer Invest. 2020 11; 38(10):537-542.
Score: 0.912
-
COVID-19, Cancer, and Consequences: Where Are We Now? Cancer Invest. 2020 Sep; 38(8-9):431-435.
Score: 0.903
-
Personalized cancer supportive care in COVID-19 era. Ann Oncol. 2020 07; 31(7):835-837.
Score: 0.882
-
Evolving Landscape of US Food and Drug Administration Drug Approval in the Era of Precision Oncology: Finding the Right Balance Between Access and Safety. J Clin Oncol. 2018 06 20; 36(18):1773-1776.
Score: 0.767
-
Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer. Thromb Res. 2018 04; 164 Suppl 1:S112-S118.
Score: 0.761
-
Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era. Front Oncol. 2021; 11:697908.
Score: 0.239
-
Supportive care in patients with cancer during the COVID-19 pandemic. ESMO Open. 2021 02; 6(1):100038.
Score: 0.230
-
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020 06 20; 395(10241):1907-1918.
Score: 0.221
-
Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK). Oncologist. 2018 02; 23(2):247-255.
Score: 0.184
-
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial. Thromb Haemost. 2017 11 01; 117(11):2135-2145.
Score: 0.184
-
Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial. Thromb Res. 2017 Mar; 151:89-95.
Score: 0.175
-
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013 Jun 10; 31(17):2189-204.
Score: 0.136
-
The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19. J Thromb Haemost. 2021 10; 19(10):2522-2532.
Score: 0.060
-
Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis. Cancer Invest. 2021 Apr; 39(4):315-320.
Score: 0.059
-
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium. Ann Oncol. 2021 06; 32(6):787-800.
Score: 0.058
-
Mortality in hospitalized patients with cancer and coronavirus disease 2019: A systematic review and meta-analysis of cohort studies. Cancer. 2021 05 01; 127(9):1459-1468.
Score: 0.058
-
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study. Cancer Discov. 2020 10; 10(10):1514-1527.
Score: 0.056
-
Crowdsourcing a crisis response for COVID-19 in oncology. Nat Cancer. 2020; 1(5):473-476.
Score: 0.055
-
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer. N Engl J Med. 2019 02 21; 380(8):720-728.
Score: 0.051
-
External validation of three risk stratification rules in patients presenting with pulmonary embolism and cancer. Support Care Cancer. 2019 Mar; 27(3):921-925.
Score: 0.049
-
Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta-analysis. J Thromb Haemost. 2018 02; 16(2):279-292.
Score: 0.047
-
Clinical Predictors of Early Mortality in Colorectal Cancer Patients Undergoing Chemotherapy: Results From a Global Prospective Cohort Study. JNCI Cancer Spectr. 2017 Sep; 1(1):pkx009.
Score: 0.046